Mid career · publishing since 2010Rising activity
Myeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors
Publications
129
Citations
1,233
Est. group size
~13
Recurring co-author estimate
Active years
17
Publishing since 2010
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 1,233p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 15.4p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~13 · 0% small-team papers (≤3 authors) · across 0 venues
Publication cadence
Publications per year over the last 10 years — averaging 15.4/year recently
Recent publications
- Supplementary Figure 6. Effects of caspase inhibitors alone on myeloma cell viability. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 7. Immunofluorescent localization of Fas and p62. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Materials and Methods from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 3. Western blot analysis of myeloma PC derived from three relapsed/refractory patients treated with selinexor and carfilzomib, alone and in combination. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 5. Anti-tumor response of all groups of mice treated with carfilzomib or selinexor alone and in combination. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Materials and Methods from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Data from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 4. Changes in body weight of mice receiving single agent or combination treatment with selinexor or carfilzomib. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 4. Changes in body weight of mice receiving single agent or combination treatment with selinexor or carfilzomib. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 3. Western blot analysis of myeloma PC derived from three relapsed/refractory patients treated with selinexor and carfilzomib, alone and in combination. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 7. Immunofluorescent localization of Fas and p62. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 6. Effects of caspase inhibitors alone on myeloma cell viability. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 5. Anti-tumor response of all groups of mice treated with carfilzomib or selinexor alone and in combination. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Data from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
- Supplementary Figure 1. Effects of long term pan-caspase inhibition on autophagy in myeloma cells. from Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor
2023
Publishes in
- Blood×15
- Clinical Lymphoma Myeloma & Leukemia×9
- Blood Advances×4
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Oncotarget×3
Similar researchers
By research-topic overlap
- Kristen Pettit
Medicine · University of Michigan
- Veena Fauble
Medicine · University of Michigan
- Harrison S. Greenbaum
Medicine · University of Michigan
- Andrea Sipos
Medicine · University of Michigan
- James Yoon
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile